Contact Lens Complication

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alcon
AlconFORT WORTH, TX
2 programs
TOTAL30 for Astigmatism Contact LensesN/A1 trial
Total30 for Astigmatism Contact LensesN/A1 trial
Active Trials
NCT06052046CompletedEst. Jun 2024
NCT06266728CompletedEst. Aug 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AlconTotal30 for Astigmatism Contact Lenses
AlconTOTAL30 for Astigmatism Contact Lenses

Clinical Trials (2)

NCT06266728AlconTotal30 for Astigmatism Contact Lenses

T30 for Astigmatism in Digital Device Users

Start: Mar 2024Est. completion: Aug 2024
N/ACompleted
NCT06052046AlconTOTAL30 for Astigmatism Contact Lenses

Total30 for Astigmatism Contact Lenses

Start: Oct 2023Est. completion: Jun 2024
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space